Forschungs- & Entwicklungsinformationsdienst der Gemeinschaft - CORDIS

FP5

MIVASE Berichtzusammenfassung

Project ID: QLG1-CT-2000-01801
Gefördert unter: FP5-LIFE QUALITY
Land: United Kingdom

Antibody effective in inhibiting extracellular acidification

Antibodies have been developed which show high specificity towards the specific proteins expressed in osteoblasts and a range of cancer cells. One of these antibodies can inhibit bone resorption due to osteoclasts and the migration of metastatic cancer cells in culture. Patents covering these discoveries are in the process of submission. The results have clear potential for immunotherapeutic approaches to osteoporosis and cancer.

Verwandte Informationen

Kontakt

John B C FINDLAY, (Head of Research Group)
Tel.: +44-113-33433140
Fax: +44 113-3433167
E-Mail-Adresse
Folgen Sie uns auf: RSS Facebook Twitter YouTube Verwaltet vom Amt für Veröffentlichungen der EU Nach oben